'Cell lymphoma' diaporamas de présentation

Mature Lymphoid Neoplasms

2.43k views • 146 slides

BTK inhibition in mantle cell and diffuse large cell lymphoma: the next steps

BTK inhibition in mantle cell and diffuse large cell lymphoma: the next steps. Kristie A. Blum, MD Associate Professor of Medicine Section Head, OSU Lymphoma Program. Discussion topics. Single agent ibrutinib trials Combination ibrutinib trials Prognostic factors in MCL and DLCL

984 views • 74 slides

806 views • 67 slides

LYMPHOMA

1.2k views • 61 slides

Linfoma no hodgkin

1.72k views • 47 slides

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2012

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2012. Summary Slides. SUM12_1.ppt. Location of Centers Participating in the CIBMTR 2012. Slide 2. SUM12_22.ppt. Transplant Activity in the U.S. 1980-2011. Transplants. Slide 3. SUM12_23.ppt.

654 views • 44 slides

An old man has decrease in vision

An old man has decrease in vision. Presented by: Khalid Bedaiwi , MD R1 Supervised by: Abdullah Alfawaz , MD, FRCS Anterior segment and uveitis consultant, King Saud University. History. 71 year old Saudi gentle man. K/C of RHD, HTN and CKD.

841 views • 38 slides

Journal Reading

582 views • 38 slides

Unlocking the Future of B-Cell Lymphoma ? Molecular Basis for Innovative Approaches

Unlocking the Future of B-Cell Lymphoma ? Molecular Basis for Innovative Approaches. Program Goals. Concluding Remarks. Abbreviations. Abbreviations (cont). Abbreviations (cont). Abbreviations (cont). References. References (cont). References (cont). References (cont). References (cont).

456 views • 36 slides

Pharmacogenomics: Changing The Paradigm

Pharmacogenomics: Changing The Paradigm . Aidan Power MD Clinical Pharmacogenomics Pfizer Global Research and Development. Presentation. Why do genetics/pharmacogenomics? Types of studies Uses in drug development Drug Discovery Drug Development Applications of gene expression

541 views • 35 slides

CARCINOGENIC AGENTS AND TUMOR IMMUNOLOGY

CARCINOGENIC AGENTS AND TUMOR IMMUNOLOGY. DAVID LEWIN MD. OVERVIEW. Three Classes of Carcinogens Chemical Radiation Viral Tumor Immunology Tumor Antigens Antitumor Effector Mechanisms Immunosurveillance Immunotherapy. CHEMICAL CARCINOGENS. Natural and Synthetic Agents

1.13k views • 32 slides

Non-Hodgkin lymfoom

Non-Hodgkin lymfoom. Mark-David Levin. Hemato-poiese. Normaal. Kaushansky K. N Engl J Med 2006;354:2034-2045. Lymfomen. Non-Hodgkin lymfoom. 85%. Hodgkin lymfoom. 15%. Kaushansky K. N Engl J Med 2006;354:2034-2045. Lymfomen. Non-Hodgkin lymfoom. 85%.

539 views • 28 slides

Answer

686 views • 24 slides

Lymphoma

529 views • 21 slides

Apoptosis, Oxidative Stress and Cancer

The Virtual Free Radical School. Apoptosis, Oxidative Stress and Cancer. Margaret E. Tome and Margaret M. Briehl. Department of Pathology P.O. Box 245043 The University of Arizona Tucson, AZ 85724 Tel: (520) 626-6771 (MET) Tel: (520) 626-6827 (MMB) Email: mtome@u.arizona.edu

406 views • 20 slides

Linfoma no hodgkin

453 views • 17 slides

709 views • 14 slides

4 th Cutaneous Lymphoma Patient Educational Forum

4 th Cutaneous Lymphoma Patient Educational Forum. Saturday April 14, 2012 Cummings Auditorium Women's College Hospital. Cutaneous Lymphoma Foundation Phototherapy Education and Research Centre (PERC) Women's College Hospital. WHO-EORTC Classification of Cutaneous T-cell Lymphomas:.

396 views • 12 slides

5.1b. Post-contrast Coronal T1 Wtd MRI

5.1a. Post-contrast Axial T1 Wtd MRI. 5.1b. Post-contrast Coronal T1 Wtd MRI. A 52 year-old male with corpus callosal tumor. Q1. Diagnosis Please. A 60 year-old male with known hemopoetic systemic disease. Q2. Diagnosis Please. 5.2. Post-contrast Coronal T1 Wtd MRI.

175 views • 9 slides

NF- ?B

HEMATOLOGICAL MALIGNANCIES. SOLID TUMORS. Breast Cancer Cervical Cancer Prostate Cancer Renal Cancer Lung Cancer Colon Cancer Liver Cancer Pancreatic Cancer Esophageal Cancer Gastric Cancer Laryngeal Cancer Thyroid Cancer Parathyroid Cancer Melanoma Bladder Cancer Cylindroma

456 views • 4 slides